Jinzhou Jiutai Pharmaceutical

Jinzhou Jiutai Pharmaceutical is a comprehensive pharmaceutical manufacturer based in Jinzhou, Liaoning Province, China. Originally established in 1951 as the Jinzhou No. 1 Pharmaceutical Factory, the company underwent a successful corporate restructuring in 1998 to become a modern limited liability enterprise. It is a major global producer of Active Pharmaceutical Ingredients (APIs) and finished dosages, particularly specializing in gastrointestinal treatments such as Cimetidine and Sucralfate. The company is also well-regarded for its proprietary probiotic product, Jinshuangqi, which is used to treat intestinal flora imbalances. Jiutai Pharmaceutical operates multiple GMP-certified production lines and maintains a significant export presence in over 30 countries across Southeast Asia, Europe, and the Americas.